Conclusion
La thérapie photodynamique est une méthode thérapeutique anticancéreuse originale et très séduisante. Après une longue période de doute, un renouveau apparaît grâce à l'apport de nouvelles technologies notamment au niveau des sources de lumières laser plus accessibles sur le plan financier et technique et aussi par le développement actuel et futur de nouvelles molécules photosensibilisantes plus adaptées aux différentes pathologies cancéreuses et plus sûres. Ces nouvelles thérapeutiques devront toutefois faire la preuve de leur efficacité et se situer par rapport aux autres méthodes thérapeutiques.
Références
RAAB O. — Uber die wirkung fluoreszierenden Stoffen.Infusaria Z. biol., 1900,39, 524.
TAPPEINER H.V., JESONIEK A. — Therapeutische Versuch mit fluoreszierender Stoff.Muchen Med. Wehnschr., 1903,1, 2042–2044.
DOUGHERTY T.J., KAUFMAN J.E., GOLDFARB A. — Photoradiation therapy for the treatment of malignant tumors.Cancer Res., 1978,38, 2628–2635.
POLICARD A. — Etude sur les aspects offerts par les tumeurs expérimentales examinées à la lumière de wood. Comptes rendus.Soc. Biol., 1924,91, 1423–1424.
MOAN J., PENG Q., SORENSEN R., IANI V., NESLAND J.M. — The biophysical foundations of photodynamic therapy.Endoscopy, 1998,30, 387–391.
SELVASEKAR C.R., BIRBECCK N., McMILLAN T., WAINWRIGHT M., WALKER S.J. — Review article: photodynamic therapy and the alimentary tract.Aliment. Pharmacol. Ther., 2001,15, 899–915.
BARR H., DIX A.J., KENDALL C., STONE N. — Review article: the potential role for photodynamic therapy in the management of upper gastrointestinal disease.Aliment. Pharmacol. Ther., 2001,15, 311–321.
LIGHTDALE C.J., HEIER S.K., MARCON N.E. — Photodynamic therapy with porfimer sodium versus thermal ablation with Nd-YAG laser for palliation of oesophageal cancer: a multicentre randomised trial.Gastrointest. Endosc., 1995,42, 507–512.
HEIER S.K., ROTHMAN K.A., HEIER L.M., ROSENTHAL W.S. — Photodynamic therapy for obstructing oesophageal cancer: light dosimetry and randomized comparison with Nd-YAG laser therapy.Gastroenterology, 1995,109, 63–72.
MOGHISSI K., DIXON K., THORPE J.A.C. — The role of photodynamic therapy (PDT) in inoperable oesophageal cancer.Eur. J. Cardio-Thorc. Surg., 2000,17, 95–100.
SIBILLE A., LAMBERT R., SOUQUET J.C., SABBEN G., DESCOS F. — Long term survival after photodynamic therapy for esophageal cancer.Gastroenterology, 1995,108, 337–344.
SAVARY J.F., GROSJEAN P., MONNIER P., FONTOLLIET C., WAGNIERES G., BRAICHOTTE D.et al. — Photodynamic therapy of early squamous cell carcinomas of the oesophagus.Endoscopy, 1998,30, 258–265.
CORTI L., SKARLATOS J., BOSO C. — Outcome of patients receiving photodynamic therapy for early esophageal cancer.Int. J. Rad. Oncol. Biol. Phys., 2000,47, 419–424.
OVERHOLT B.F., PANJEHPOUR M., TEFFETELLAR E., ROSE M. — Photodynamic therapy for treatment of early adenocarcinoma in Barrett’s esophagus.Gastrointest. Endosc., 1993,39, 73–76.
OVERHOLT B.F., PANJEHPOUR M., HAYDEK J.M. — Photodynamic therapy for Barrett’s esophagus: follow-up in 100 patients.Gastrointest. Endosc., 1999,49, 1–7.
OVERHOLT B.F., PANJEHPOUR M., HAYDEK J.M. — Photodynamic therapy for Barrett’s esophagus with dysplasia: long term results.Gastroenterology DDW, 2001.
WANG K.K. — Current status of photodynamic therapy of Barrett’s esophagus.Gastrointest. Endosc., 1999,49, S20–23.
BARR H., SHEPERD N.A., ROBERT D.J.H. — Eradication of high grade dysplasia in columnar lined (Barrett’s) esophagus by photodynamic therapy with endogenously generated protoporphyrin IX.Lancet, 1996,348, 584–585.
GOSSNER L., STOLTE M., SROKA R., RICK K., MAY A., HAHN E.G.et al. — Photodynamic ablation of high-grade dysplasia and early cancer in Barrett’s esophagus by means of 5-Aminolevulinic Acid.Gastroenterology, 1998,114, 448–455.
ACKROYD R., BROWN N.J., DAVIS M.F., STEPHENSON T.J., MARCUS S.L., STODDARD C.J.et al. — Photodynamic therapy for dysplastic Barrett’s oesophagus: a prospective, double blind, randomised, placebo controlled trial.Gut, 2000,47, 612–617.
KATO H., SAKAI H., KAWAGUCHI M. — Experiences with photodynamic therapy in early gastric cancer.Onkologie, 1992,15, 23–27.
ELL C., GOSSNER L., MAY A., SCHNEIDER H.T., HAHN E.G., STOLTE M.et al. — Photodynamic ablation of early cancers of the stomach by means of mTHPC and laser irradiation. Preliminary clinical experience.Gut, 1998,43, 345–349.
ABULAFI A.M., ALLARDICE J.T., WILLIAMS N.S., VAN SOMEREN N., SWAINC P., AINLEY C. — Photodynamic therapy for malignant tumours of the ampulla of Vater.Gut, 1995,36, 853–856.
WONG KEE SONG L.M., WANG K.K., ZINSMEISTER A.R. — Mono-l-asartyl chlorin e6 (Npe6) and hematoporphyrin derivative (HpD) in photodynamic therapy administred to a human cholangiocarcinoma model.Cancer, 1998,82, 421–427.
McCAUGHAN J.S., MERTENS B.F., CHO C. — Photodynamic therapy to treat tumors of the extrahepatic biliary ducts.Arch. Surg., 1991,126, 111–113.
ORTNER M.A., LIEBETRUTH J., SCHREIBER S., HANFT M., WRUCK U., FUSCO V.et al. — Photodynamic therapy of non resectable cholangiocarcinoma.Gastroenterology, 1998,114, 536–542.
ORTNER M.A., LIEBETRUTH J., GIESSE A. — Photodynamic therapy of non-resectable cholangiocellular carcinoma.Gastroenterology, 1998,114, A534.
BERR F., WIEDMANN M., TANNAPFEL A., HALM U., KOHLHAW K.R., SCHMIDT F.et al. — Photodynamic therapy for advanced bile duct cancer: evidence for improved palliation and extended survival.Hepatology, 2000,31, 291–298.
ZOEPF T., JAKOBS R., ARNOLD J.C., APPEL D., ROSENBAUM A., RIEMANN J.F. — Photodynamic therapy for palliation of non resectable bile duct cancer. Preliminary results with a new diode laser system.Am. J. Gastroenterol., 2001,96, 2093–2097.
Author information
Authors and Affiliations
Corresponding author
About this article
Cite this article
Boyer, J. La thérapie photodynamique. Acta Endosc 31 (Suppl 4), 561–566 (2001). https://doi.org/10.1007/BF03018003
Issue Date:
DOI: https://doi.org/10.1007/BF03018003